Saurashtra News

Choroideremia Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – Zazz, Otsuko Pharma

 Breaking News
  • No posts were found

Choroideremia Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – Zazz, Otsuko Pharma

September 14
18:51 2023
Choroideremia Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies - Zazz, Otsuko Pharma
DelveInsight Business Research LLP
DelveInsight’s “Choroideremia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Choroideremia, historical and forecasted epidemiology as well as the Choroideremia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Choroideremia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Choroideremia, historical and forecasted epidemiology as well as the Choroideremia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Choroideremia Key Highlights 

  • Key Companies working in the Choroideremia market include Jazz Pharmaceuticals, Otsuka Pharmaceuticals, Bionomics Limited and many others 

  • Key Therapies included in the Choroideremia market include Brexpiprazole, BNC201, and many others 

Choroideremia Overview

Choroideremia is a rare, X-linked recessive form of hereditary retinal degeneration that affects roughly 1 in 50,000 males. The disease causes a gradual loss of vision, starting with childhood night blindness, followed by peripheral vision loss and progressing to loss of central vision later in life. Progression continues throughout the individual’s life, but both the rate of change and the degree of visual loss are variable among those affected, even within the same family.

Choroideremia is caused by a loss-of-function mutation in the CHM gene which encodes Rab escort protein 1 (REP1), a protein involved in the lipid modification of Rab proteins. While the complete mechanism of disease is not fully understood, the lack of a functional protein in the retina results in cell death and the gradual deterioration of the retinal pigment epithelium (RPE), photoreceptors, and the choroid.

Choroideremia Epidemiology Insights

  • Choroideremia is a rare chorioretinal dystrophy that is estimated to affect between 1 in 50,000 to 1 in 100,000 individuals.

Click here to learn more about the Choroideremia Market Landscape

 The Report Covers the Choroideremia Epidemiology Segmented by:

  • Choroideremia prevalent cases 

  • Choroideremia incident cases 

  • Choroideremia treatment cases 

  • Choroideremia diagnosed cases 

Choroideremia Market Outlook 

The Choroideremia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Choroideremia market trends by analyzing the impact of current Choroideremia therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Choroideremia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Choroideremia market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Choroideremia market in 7MM is expected to witness a major change in the study period 2019-2032.

 Key Companies Working in the Choroideremia Market 

  • Jazz Pharmaceuticals

  • Otsuka Pharmaceuticals

  • Bionomics Limited

And many others 

 

Choroideremia Therapies Covered and Analyzed in the Report

  • Brexpiprazole 

  • BNC201

And many others 

And many others 

Learn more about the Key Companies and Emerging Therapies in the Choroideremia Market

Table of Contents 

  1.  Key Insights 

  2.  Choroideremia Introduction 

  3.  Executive Summary of Choroideremia         

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  Choroideremia Emerging Therapies

  7.  Choroideremia Market Outlook

  8.  Market Access and Reimbursement of Therapies

  9.  Market Drivers 

  10.  Market Barriers 

  11.  Appendix

  12.  Report Methodology

  13.  DelveInsight Capabilities

  14.  Disclaimer

Learn about the detailed offerings of the report @ Choroideremia Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services